Gasless extra-corporeal carbon dioxide removal

US11298447B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11298447-B2
Application numberUS-201916266193-A
CountryUS
Kind codeB2
Filing dateFeb 4, 2019
Priority dateFeb 4, 2019
Publication dateApr 12, 2022
Grant dateApr 12, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A carbon dioxide absorption medium. The absorption medium includes a plurality of hollow fibers and a plurality of binder particles. The hollow fibers have walls comprising a selectively permeable membrane that is configured to permit passage of gaseous carbon dioxide but not liquids. The plurality bind particles are dispersed between the hollow fibers and comprise an absorbent material configured to absorb gaseous carbon dioxide and to bind the carbon dioxide in a solid state.

First claim

Opening claim text (preview).

What is claimed is: 1. A carbon dioxide absorption medium comprising: a plurality of hollow fibers, each hollow fiber of the plurality having a proximal end, a distal end, a lumen extending between the proximal and distal ends, and a wall surrounding the lumen, the wall of each hollow fiber of the plurality comprising a membrane selectively permeable to gaseous carbon dioxide; and a plurality of binder particles dispersed between hollow fibers of the plurality, each binder particle of the plurality being configured to absorb gaseous carbon dioxide and to bind and to retain the carbon dioxide in a solid state. 2. The carbon dioxide absorption medium of claim 1 , wherein the membrane comprising the wall of each hollow fiber of the plurality comprises at least one polymer selected from the group consisting of cellulose acetate, cellulose triacetate, polyamide, polysulfone, polyethersulfone (PES), polyacrylonitrile (PAN), sulfonated polyacrylonitrile, polymethylmethacrylate (PmmA), and polymethylpentene (PMP). 3. The carbon dioxide absorption medium of claim 1 , wherein the wall of each hollow fiber of the plurality has an outer thickness ranging from about 5 μm to about 50 μm. 4. The carbon dioxide absorption medium of claim 1 , wherein the binder particles of the plurality have a maximum dimension ranging from about 100 μm to about 10,000 μm. 5. The carbon dioxide absorption medium of claim 1 , wherein the plurality of binder particles comprise at least one absorbent material selected from the group consisting of sodium oxide, sodium hydroxide, calcium oxide, calcium hydroxide, potassium hydroxide, lithium hydroxide, lithium peroxide, lithium carbonate, and lithium chloride. 6. A carbon dioxide absorption cartridge for removing carbon dioxide from the blood of a patient, the cartridge comprising: a housing having an inlet port and an outlet port and an internal cavity therebetween, the inlet port configured to fluidically receive blood from the patient and the outlet port configured to fluidically return filtered blood to the patient; and the carbon dioxide absorption medium of claim 1 disposed within the internal cavity of the housing. 7. The cartridge of claim 6 , wherein the membrane comprising the wall of each hollow fiber of the plurality comprises at least one polymer selected from the group consisting of cellulose acetate, cellulose triacetate, polyamide, polysulfone, polyethersulfone (PES), polyacrylonitrile (PAN), sulfonated polyacrylonitrile, polymethylmethacrylate (PmmA), and polymethylpentene (PMP). 8. The cartridge of claim 6 , wherein the wall of each hollow fiber of the plurality has an outer thickness ranging from about 5 μm to about 50 μm. 9. The cartridge of claim 6 , wherein the binder particles of the plurality have a maximum dimension ranging from about 100 μm to about 10,000 μm. 10. The cartridge of claim 6 , wherein the plurality of binder particles comprise at least one absorbent material selected from the group consisting of sodium oxide, sodium hydroxide, calcium oxide, calcium hydroxide, potassium hydroxide, lithium hydroxide, lithium peroxide, lithium carbonate, and lithium chloride. 11. The cartridge of claim 6 , wherein the internal cavity of the housing comprising a first partition and a second partition fluidically isolated from the first partition, wherein the proximal ends of the hollow fibers of the plurality extend into the first partition while the distal ends of the hollow fibers of the plurality and the plurality of binder particles reside within the second partition such that flow of blood through the housing is restricted to flow through the plurality of hollow fibers. 12. The cartridge of claim 6 , wherein the absorption medium removes carbon dioxide from the blood at a rate ranging from about 50 mL/min to about 100 mL/min as measured at about atmospheric pressure and at a temperature from about 35° C. to about 39° C. 13. The cartridge of claim 6 , wherein the blood flows through the absorption medium at a rates ranging from about 0.2 L/min to about 0.5 L/min. 14. A blood treatment system comprising: the carbon dioxide absorption cartridge of claim 6 ; a first blood flow pathway extending between a patient and the inlet port of the housing of the carbon dioxide absorption cartridge; and a second blood flow pathway extending between the outlet port of the housing of the carbon dioxide absorption cartridge and the patient. 15. The blood treatment system of claim 14 , further comprising: a pump configured to pump blood between the patient and the carbon dioxide absorption cartridge along the first and second blood flow pathways. 16. The blood treatment system of claim 14 , further comprising: a dialyzer along the first blood flow pathway or the second blood flow pathway and configured to perform hemodialysis. 17. A method for removing carbon dioxide from blood, the method comprising: transporting blood from a patient to a carbon dioxide absorption cartridge, the carbon dioxide absorption cartridge comprising: a housing having an internal cavity therein; and a carbon dioxide absorption medium disposed within the internal cavity of the housing, the carbon dioxide absorption medium comprising a plurality of hollow fibers, each hollow fiber of the plurality having a proximal end, a distal end, a lumen extending between the proximal and distal ends, and a wall surrounding the lumen, the wall of each hollow fiber of the plurality comprising a membrane selectively permeable to gaseous carbon dioxide and a plurality of binder particles dispersed between hollow fibers of the plurality, each binder particle of the plurality being configured to absorb gaseous carbon dioxide and bind the carbon dioxide in a solid state; moving the blood through the carbon dioxide absorption cartridge, thereby removing carbon dioxide from the blood; and transporting the blood from the carbon dioxide absorption cartridge to the patient, wherein neither a carrier fluid flow nor a sweep fluid flow is required for removing carbon dioxide from the blood of the patient. 18. The method of claim 17 , wherein the membrane comprising the wall of each hollow fiber of the plurality comprises at least one polymer selected from the group consisting of cellulose acetate, cellulose triacetate, polyamide, polysulfone, polyethersulfone (PES), polyacrylonitrile (PAN), sulfonated polyacrylonitrile, polymethylmethacrylate (PmmA), and polymethylpentene (PMP). 19. The method of claim 17 , wherein the wall of each hollow fiber of the plurality has an outer thickness ranging from about 5 μm to about 50 μm and the binder particles of the plurality have a maximum dimension ranging from about 100 μm to about 10,000 μm. 20. The method of claim 17 , wherein the plurality of binder particles comprise at least one absorbent material selected from the group consisting of sodium oxide, sodium hydroxide, calcium oxide, calcium hydroxide, potassium hydroxide, lithium hydroxide, lithium peroxide, lithium carbonate, and lithium chloride. 21. The method of claim 17 , wherein carbon dioxide is removed from the blood at a rate ranging from about 50 mL/min to about 100 mL/min. 22. The method of claim 17 , wherein blood flows through carbon dioxide absorption cartridge at a range ranging from about 0.2 L/min to about 0.5 L/min. 23. The cartridge of claim 6 , wherein neither a carrier fluid flow nor a sweep fluid flow is required for removing carbon dioxide from the blood of the pa

Assignees

Inventors

Classifications

  • Two or more types of hollow fibres within one bundle or within one potting or tube-sheet · CPC title

  • Polyacrylonitrile · CPC title

  • by absorption (A61M1/3675 takes precedence) · CPC title

  • Adsorbents within the flow path · CPC title

  • Absorption or adsorption · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11298447B2 cover?
A carbon dioxide absorption medium. The absorption medium includes a plurality of hollow fibers and a plurality of binder particles. The hollow fibers have walls comprising a selectively permeable membrane that is configured to permit passage of gaseous carbon dioxide but not liquids. The plurality bind particles are dispersed between the hollow fibers and comprise an absorbent material configu…
Who is the assignee on this patent?
Us Gov Air Force, Us Air Force
What technology area does this patent fall under?
Primary CPC classification A61M1/3486. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).